Overview
High-dose-rate (HDR) brachytherapy demands environments where safety, precision, and control are absolute. In these treatments, a high-energy radiation source is placed directly at or near the tumour site, enabling highly targeted therapy delivered through a series of short, efficient outpatient procedures.
With sources such as Iridium-192 operating at high dose rates, shielding design becomes critical to protecting staff, patients, and surrounding areas. NELCO works closely with project teams to develop HDR environments that meet stringent safety requirements while supporting clinical efficiency and workflow.
From initial design through final installation, NELCO delivers shielding solutions that ensure regulatory compliance, operational reliability, and peace of mind, so clinicians can focus on what matters most: patient care.
